CN Patent

CN118724879B — 一种氘代稠环化合物及其制备方法与用途

Assigned to Nanjing Zhihe Medical Technology Co ltd · Expires 2025-02-11 · 1y expired

What this patent protects

本发明提供如式(I)所示的稠环化合物及其制备方法与用途，该化合物可显著改善睡眠状况，可开发为治疗和预防失眠的药物，同时适合开发为多种剂型。

USPTO Abstract

本发明提供如式(I)所示的稠环化合物及其制备方法与用途，该化合物可显著改善睡眠状况，可开发为治疗和预防失眠的药物，同时适合开发为多种剂型。

Drugs covered by this patent

daridorexant-hydrochloride (DARIDOREXANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN118724879B
Jurisdiction: CN
Classification: —
Expires: 2025-02-11
Drug substance claim: No
Drug product claim: No
Assignee: Nanjing Zhihe Medical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.